Silo Pharma (SILO) Debt Ratio (2012 - 2023)

Silo Pharma (SILO) posted Debt Ratio of 0.06 for Q1 2023, up 91.47% sequentially from 0.03 in Q4 2022, and up 797.49% YoY from 0.01 in Q1 2022.

Silo Pharma (SILO) Debt Ratio (2012 - 2023) Analysis & Trends

Silo Pharma has reported Debt Ratio for 6 years, with the latest figure at 0.06 in Q1 2023.

Quarterly Debt Ratio rose 797.49% year-over-year to 0.06 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was 0.06 (up 797.49% YoY) and the FY2022 annual result came in at 0.03, down 21.48% from the prior year.
Debt Ratio advanced to 0.06 in Q1 2023 per SILO's latest filing, from 0.03 in the prior quarter.
Over five years, Debt Ratio peaked at 0.06 in Q1 2023 and troughed at 0.0 in Q1 2021.
A 4-year average of 0.02 and a median of 0.01 in 2020 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2021 and 2022: Debt Ratio jumped 1238.66% in 2021, then plunged 84.22% in 2022.
Over 4 years, Debt Ratio stood at 0.0 in 2020, then surged by 1238.66% to 0.04 in 2021, then fell by 21.48% to 0.03 in 2022, then surged by 91.47% to 0.06 in 2023.
According to Business Quant data, Debt Ratio over the past three periods registered 0.06, 0.03, and 0.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	139.59 Bn	131.73 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.21 Bn	78.22 Bn	3.93 Bn	0.05
3	Argenx Se	65.65 Bn	60.47 Bn	1.37 Bn	-
4	Moderna	57.67 Bn	52.53 Bn	52.00 Mn	0.05
5	BeOne Medicines	42.10 Bn	37.00 Bn	1.53 Bn	0.12
6	Alnylam Pharmaceuticals	31.62 Bn	28.31 Bn	992.69 Mn	-
7	BioNTech SE	27.90 Bn	9.51 Bn	668.28 Mn	0.03
8	Insmed	27.51 Bn	26.35 Bn	358.27 Mn	0.26
9	Royalty Pharma	27.29 Bn	26.45 Bn	-	0.47
10	Silo Pharma	2.93 Mn	2.93 Mn	-	-

Download Data